June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Wide-Field Swept-Source Optical Coherence Tomography Angiography (WF SS-OCTA) Vascular Metrics Reveal a Larger Effect Size on Contrast Sensitivity than Visual Acuity in Retinal Vein Occlusion
Author Affiliations & Notes
  • Peyman Razavi
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Grace Baldwin
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Luis Martinez-Velazquez
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Itika Garg
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Filippos Vingopoulos
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Hannah Choi
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Hannah Wescott
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Jack Tracy
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ines Lains
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Matthew Finn
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Augustine Bannerman
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Rebecca Zeng
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • David M Wu
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Leo A Kim
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Demetrios Vavvas
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • John B Miller
    1. Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    2. Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Peyman Razavi None; Grace Baldwin None; Luis Martinez-Velazquez None; Itika Garg None; Filippos Vingopoulos None; Hannah Choi None; Hannah Wescott None; Jack Tracy None; Ines Lains None; Matthew Finn None; Augustine Bannerman None; Rebecca Zeng None; David Wu Massachusetts Eye and Ear, Code P (Patent); Leo Kim National Eye Institute (R01EY027739) and CureVac AG, Code F (Financial Support), Pykus Therapeutics, Code I (Personal Financial Interest), Massachusetts Eye and Ear, Code P (Patent); Demetrios Vavvas Valitor and OliX Pharmaceuticals, Code C (Consultant/Contractor), The National Institute of Health (R01EY025362 and R21EY0203079), National Eye Institute, Research to Prevent Blindness, Loefflers Family Foundation, Yeatts Family Foundation, and Alcon Research Institute, Code F (Financial Support); John Miller Alcon, Topcon, Allergan, Carl Zeiss, Sunovion, and Genentech, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1788. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Peyman Razavi, Grace Baldwin, Luis Martinez-Velazquez, Itika Garg, Filippos Vingopoulos, Hannah Choi, Hannah Wescott, Jack Tracy, Ines Lains, Matthew Finn, Augustine Bannerman, Rebecca Zeng, David M Wu, Leo A Kim, Demetrios Vavvas, John B Miller; Wide-Field Swept-Source Optical Coherence Tomography Angiography (WF SS-OCTA) Vascular Metrics Reveal a Larger Effect Size on Contrast Sensitivity than Visual Acuity in Retinal Vein Occlusion. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1788.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : WF SS-OCTA is a non-invasive option for assessing the retinal microvasculature in eyes with retinal vein occlusion (RVO). We sought to evaluate the relationship between WF SS-OCTA and contrast sensitivity (CS), compared to visual acuity (VA), in eyes with RVO.

Methods : This cross-sectional study included 64 eyes of 37 patients with RVO that were tested with the Quantitative CS Function (qCSF) test (Adaptive Sensory Technology) on the same day as imaging with WF SS-OCTA (PLEX® Elite 9000, Carl Zeiss Meditec). Outcomes included Snellen’s VA reported as LogMAR and response to different contrast levels. The microvasculature measurements analyzed included vessel density (VD) and vessel skeletonized density (VSD) in the superficial (SCP) and deep (DCP) capillary plexus, and whole retina (WR), and foveal avascular zone (FAZ) parameters on 3, 6, and 12 mmxmm images. Mixed effects multivariable regression models controlling for age and lens status were performed. Standardized beta coefficients were calculated by refitting the standardized data.

Results : Regression results revealed that both VA and CS were significantly associated with the OCTA vascular metrics on all three angiogram dimensions. Among the 3 mmxmm images, the largest standardized beta coefficients were between CS at 1 cpd and VD and VSD in the DCP (β = 0.54, β = 0.52, p < 0.001), and between VA and FAZ perimeter and circularity (β = 0.50, β = 0.50, p < 0.001). On 6 mmxmm images, the largest standardized beta coefficients were between VA and VSD in the SCP and WR (β = -0.52, β = -0.51, p = 0.001), and between AULCSF and VSD in the SCP (β = 0.49, p = 0.001). On 12 mmxmm images, VA was significantly associated with VD in the SCP (β = -0.34, p = 0.036) and WR (β = -0.36, p = 0.025), but was not significantly associated with VSD. On the other hand, multiple CS metrics revealed significant associations with both VD and VSD on 12 mmxmm images. The largest effect size was between CS at 3 cpd and VD in the WR (β = 0.50, p = 0.002) (Table1).

Conclusions : Our results indicate that CS is associated with the microvasculature changes of RVO. Given the strong associations of CS with patient reported visual outcomes, the routine evaluation of CS combined with WF SS-OCTA may be supported in the clinical management of RVO.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×